Vistin Pharma ASA (VISTN) will announce its third quarter and YTD 2025 results on October 31, 2025. A conference call will be held at 08:30 CET on the same day for shareholders and interested parties, with a Q&A session following the management discussion. The call will be conducted in English and available via webcast and telephone conference. Vistin Pharma is a Norwegian pharmaceutical company specializing in Metformin production, headquartered in Oslo, Norway, with a manufacturing facility in Kragerø. For more information, contact CFO Alexander Karlsen at +47 97053621 or [email protected].

Read more at GlobeNewswire: Invitation to Q3 2025 conference call